KONINKL. PHILIPS ADR -,20KONINKL. PHILIPS ADR -,20KONINKL. PHILIPS ADR -,20

KONINKL. PHILIPS ADR -,20

No trades
See on Supercharts
Market capitalization
‪17.26 B‬EUR
‪−456.45 M‬EUR
‪17.80 B‬EUR
‪906.39 M‬
Beta (1Y)
0.76

About KONINKL. PHILIPS ADR -,20

CEO
Roy Jakobs
Headquarters
Amsterdam
Employees (FY)
‪69.66 K‬
Founded
1891
ISIN
US5004723038
FIGI
BBG000HQ3839
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange KONINKL. PHILIPS ADR -,20 stocks are traded under the ticker PHIA.
One year price forecast for KONINKL. PHILIPS ADR -,20 has a max estimate of 29.3 EUR and a min estimate of 16.3 EUR.
Yes, you can track KONINKL. PHILIPS ADR -,20 financials in yearly and quarterly reports right on TradingView.
PHIA net income for the last quarter is ‪124.46 M‬ EUR, while the quarter before that showed ‪−587.48 M‬ EUR of net income which accounts for 121.18% change. Track more KONINKL. PHILIPS ADR -,20 financial stats to get the full picture.
Like other stocks, PHIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KONINKL. PHILIPS ADR -,20 stock right from TradingView charts — choose your broker and connect to your account.
PHIA reached its all-time high on Sep 6, 2000 with the price of 53.4 EUR, and its all-time low was 10.1 EUR and was reached on Mar 31, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪69.66 K‬ employees. See our rating of the largest employees — is KONINKL. PHILIPS ADR -,20 on this list?
We've gathered analysts' opinions on KONINKL. PHILIPS ADR -,20 future price: according to them, PHIA price has a max estimate of 29.26 EUR and a min estimate of 16.29 EUR. Read a more detailed KONINKL. PHILIPS ADR -,20 forecast: see what analysts think of KONINKL. PHILIPS ADR -,20 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KONINKL. PHILIPS ADR -,20 EBITDA is ‪2.03 B‬ EUR, and current EBITDA margin is 11.46%. See more stats in KONINKL. PHILIPS ADR -,20 financial statements.